NovaCath Integrated IV Catheter System Launched In Canada
Tangent Medical has internationally launched its patented NovaCath integrated intravenous (IV) catheter system in Canada after receiving clearance from Health Canada.
NovaCath is a next-generation technology designed to address several complex IV therapy challenges including catheter stabilisation, occupational exposure to blood, patient and healthcare worker safety and patient discomfort. It is claimed to be the first safety IV catheter offering advanced catheter stabilisation technology designed to exceed the highest Centers for Disease Control, Occupational Safety and Health Administration and Infusion Nursing Society standards for stabilisation. In February, Tangent raised a US$5mn senior secured term loan credit facility from GE Capital Healthcare Financial Services to commercialise NovaCath in larger countries where healthcare worker safety legislation has been passed.
According to Tangent, the NovaCath integrated IV catheter system is designed to reduce overall IV complications including dislodgement, infiltration, phlebitis and occlusion. Its passive needle shielding technology and closed system is designed to minimise occupational exposure to blood. The company believes that its patented design not only elevates safety, but adds a layer of comfort that has not been achievable with other IV catheters.